Journal of Oncology Translational Research

Homeopathy is medicine for the individual person. In my lecture I present the treatment of a young boy and a young girl. She was suffering from Burkitt’s lymphoma with her ups and downs and in the end with a satisfying outcome. The boy got aggressive during chemotherapy. A homeopathic remedy was able to calm him down during the following chemotherapies. Homeopathic medicine is used in addition to conventional medicine. Usually we treat patients by choosing a homeopathic remedy as a result of a complete anamnesis which include patient’s biography, the current complaints and the psychic and physic possibilities of reactions on daily life. During follow-ups we can clearly evaluate the efficacy of our treatment. In this presentation the suffering of a five-year old girl with a B-Non-Hodgkin Burkitt like Lymphoma will be described. The first consultation via phone was during her stay at the Intensive Care Unit because of an organic shock syndrome. Getting Phosphor and Mercurius corrosivus in homeopathic preparation extubation was possible within one day. Conventional treatment combined with homeopathic remedies was completed five months later. Some months later she got a relapse and a stem cell therapy was necessary. Severe fever attacks, abdominal pains, loss of appetite and psychic disorders could be cured by homeopathic drugs. Main remedies had been Phosphor, Scropholaria nodosa, Acidum arsenicosum. That form of Integrative Medicine enabled her survival. This case encourages us to treat patients in our practice or hospitals. The efficacy of homeopathy is also seen in calming of a young boy who got angry during chemotherapy delivering him Strychnos nux vomica.

      Journal of Oncology Translational Research with ISSN: 2476-2261 is a peer reviewed online open access journal publishes articles that includes a wide range of topics in this field of cancer and creates a platform for the authors to make their contribution towards the journal. The journal covers all aspects of modern research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients and creates a platform for the authors to contribute towards the journal.

      Trans-arterial chemoembolization is a well-supported treatment option for patients with hepatocellular carcinoma who are not surgical or transplant candidates. The efficacy relies on the ability catheterize the arteries directly feeding a tumor and inject chemo-embolic particles directly into the tumor under fluoroscopic guidance. In the presence of a vascular anomaly such as an arterio-portal or arteriohepatic shunts, the flow dynamics within the tumor are altered and may compromise conventional or drug-eluting bead trans-arterial chemoembolization. We present the case of a patient with hepatocellular carcinoma complicated by arterio-portal and arterio-hepatic vein shunts who was treated with a modified trans-arterial chemoembolization utilizing balloon-occlusion.